The Influence of Dopamine on Automatic and Controlled Semantic Activation in Parkinson’s Disease

李佳舫（2017）。The Association of Serological Protein Biomarkers with Cognitive Impairment in Parkinson's Disease〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU201700469
何應瑞、巫錫霖、王文甫、黃耀庭、鄭鈞文（2009）。Role of Glutamatergic System and Neuroimmunological Function in the Dementia of Parkinson's Disease。台灣醫學，13(1)，100-106。https://doi.org/10.6320/FJM.2009.13(1).14
Jones, J. D., Jacobson, C., Murphy, M., Price, C., Okun, M. S., & Bowers, D. (2014). Influence of Hypertension on Neurocognitive Domains in Nondemented Parkinson’s Disease Patients. Parkinson＇s Disease, (2014), 103-112. https://doi.org/10.1155/2014/507529
Daniel, J. S., Govindan, J. P., Kamath, C., D'Souza, C., Adlan, M. A., & Premawardhana, L. D. (2014). Newer Dopaminergic Agents Cause Minimal Endocrine Effects in Idiopathic Parkinson's Disease. Clinical Medicine Insights: Endocrinology and Diabetes, (2014), 13-17. https://doi.org/10.4137/CMED.S14902
Andersen, A. H., Smith, C. D., Slevin, J. T., Kryscio, R. J., Martin, C. A., Schmitt, F. A., & Blonder, L. X. (2015). Dopaminergic Modulation of Medial Prefrontal Cortex Deactivation in Parkinson Depression. Parkinson＇s Disease, 2015(), 364-374. https://doi.org/10.1155/2015/513452